Anticorps Polyclonal de lapin anti-p21
p21 Polyclonal Antibody for IF, WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
rat, souris
Applications
WB, IHC, IF, ELISA
Conjugaison
Non conjugué
N° de cat : 28248-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules PC-12, cellules DC2.4, cellules HSC-T6, cellules Neuro-2a, cellules NIH/3T3, cellules RAW 264.7, cellules Sp2/0 |
Résultats positifs en IF | cellules NIH/3T3, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunofluorescence (IF) | IF : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 21 publications below |
IHC | See 4 publications below |
IF | See 5 publications below |
Informations sur le produit
28248-1-AP cible p21 dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons rat, souris
Réactivité | rat, souris |
Réactivité citée | rat, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | p21 Protéine recombinante Ag28394 |
Nom complet | cyclin-dependent kinase inhibitor 1A (P21) |
Masse moléculaire calculée | 18 kDa |
Poids moléculaire observé | 18 kDa |
Numéro d’acquisition GenBank | NM_001111099 |
Symbole du gène | Cdkn1a |
Identification du gène (NCBI) | 12575 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for p21 antibody 28248-1-AP | Download protocol |
IF protocol for p21 antibody 28248-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Bioact Mater Chemo-immunotherapy by dual-enzyme responsive peptide self-assembling abolish melanoma | ||
Redox Biol Deficiency of S100 calcium binding protein A9 attenuates vascular dysfunction in aged mice | ||
Dev Cell Endoderm development requires centrioles to restrain p53-mediated apoptosis in the absence of ERK activity. | ||
Int J Mol Sci Revealing the Therapeutic Targets and Mechanism of Ginsenoside Rg1 for Liver Damage Related to Anti-Oxidative Stress Using Proteomic Analysis | ||
Int Immunopharmacol Aflatoxin B1 exposure triggers inflammation and premature skin aging via ERMCS/Ca2+/ROS signaling cascade | ||
Ecotoxicol Environ Saf Exploring the molecular mechanisms underlie the endoplasmic reticulum stress-mediated methylmercury-induced neuronal developmental damage |